RENBP and COVID-19: Moreover, the diagnostic performance of the proposed BG-Ag-RDTs remarkably fulfilled WHO’s recommendations for the use of Ag-RDTs in early diagnosis of COVID-19 within 5 to 7 days of symptoms onset, which recommends ≥80% sensitivity and ≥97% specificity compared with that of the PCR assay (5).